Diarrhea is a common side effect of GLP-1 medications, including semaglutide and tirzepatide. Replacing lost fluids and electrolytes is the first priority. Keep eating foods you tolerate, and contact your prescriber if diarrhea persists or keeps returning.
Urgency can make it hard to leave home without planning around a bathroom. A useful plan should address that disruption as well as the loose stools. Our GLP-1 digestive side-effects guide covers the wider range of symptoms.
Don't change your medication or dose without talking to your prescriber.
How common is diarrhea with GLP-1 medications?
Diarrhea is reported in trials of Ozempic, Wegovy, Mounjaro, Zepbound, Rybelsus, and Foundayo. The table shows the percentage of participants who reported it during each study, alongside the corresponding placebo group.
| Product and studied doses | Diarrhea with active drug | With placebo | US label revision |
|---|---|---|---|
| Wegovy injection, 2.4 mg; weight-management trials | 30% | 16% | Label 06/2026 |
| Zepbound, 5 / 10 / 15 mg; weight-management trials | 19% / 21% / 23% | 8% | Label 08/2026 |
| Ozempic injection, 0.5 / 1 mg; diabetes trials | 8.5% / 8.8% | 1.9% | Label 05/2026 |
| Mounjaro, 5 / 10 / 15 mg; diabetes trials | 12% / 13% / 17% | 9% | Label 08/2026 |
| Rybelsus, 7 / 14 mg tablets; diabetes trials | 9% / 10% | 4% | Label 01/2026 |
| Foundayo, equivalent 5.5 / 9 / 17.2 mg; weight-management trials | 21% / 23% / 25% | 11% | Label 07/2026 |
Source: US prescribing-information adverse-event tables, verified September 29, 2026; revision dates shown per row. Percentages follow the dose order listed. Foundayo trials used an investigational formulation; the label expresses equivalent marketed doses. These are separate trials, not a head-to-head comparison.
A report of diarrhea could reflect a single episode or a recurring problem. These percentages don't describe how often each person had loose stools or how much it affected daily life.
Why can diarrhea happen if GLP-1s slow stomach emptying?
Stomach emptying is one part of digestion. Slowing food's passage out of the stomach doesn't mean the entire bowel responds in the same way. Diarrhea is a documented GLP-1 side effect, although the labels don't identify a single mechanism behind every episode.
Other causes include infections, food intolerances, digestive conditions, and other medicines, according to NIDDK's diarrhea guidance. A stomach bug can happen while you're taking a GLP-1. Recent antibiotics, travel, sick contacts, or new foods can help explain a change in symptoms.
Timing is useful information. Diarrhea that begins after a prescription change gives your prescriber a different starting point from loose stools that were happening before treatment. Both deserve attention, particularly if they keep recurring or affect your ability to eat and drink.
How long does GLP-1 diarrhea last?
Digestive side effects often occur during dose escalation and become less frequent over time. In a 2022 pooled analysis of STEP 1 to 3, the median diarrhea episode in the semaglutide group lasted three days.
That study involved adults with overweight or obesity assigned to weekly semaglutide targeting 2.4 mg or placebo. Three days describes an individual episode in that study, not a deadline for your recovery. An episode can stop and another can occur later.
Track the recurring pattern as well as today's symptoms. Our guide to how long GLP-1 side effects last explains the available timeline research. The medical-help section below sets out when to contact a doctor, including diarrhea lasting more than two days.
What should you drink when you have diarrhea?
Diarrhea causes fluid loss, so replace both water and electrolytes, the salts your body needs. NIDDK's treatment guidance includes oral rehydration solutions as an option. A pharmacist can help you choose a product.
Keep drinks accessible and pay attention to whether you can keep up with fluid losses. If you have diabetes, kidney disease, or a prescribed fluid limit, check which rehydration product and amount fit your care.
Signs of dehydration include dark urine, urinating less, unusual thirst, and dizziness. Tell your clinician if these appear or if nausea and vomiting make it hard to keep fluids down. Difficulty replacing fluid losses needs assessment.
What should you eat?
Keep eating as you're able. NIDDK's nutrition guidance doesn't recommend fasting or a broadly restricted diet for acute diarrhea. When your appetite returns, you can usually return to your usual diet.
Some foods and drinks can aggravate diarrhea:
Alcohol and caffeine.
High-fat foods.
Large amounts of simple sugars, and sugar alcohols used in some sugar-free products.
Milk and other lactose-containing foods if you have temporary difficulty digesting lactose during or after an episode.
Start with foods you tolerate. Repeated patterns are more informative than one uncomfortable meal when considering a possible intolerance. A short note of what you ate and when urgency followed can be useful if the same problem happens again.
If you're gradually excluding more foods or struggling to eat enough, a dietitian can help you maintain nutrition while working through the symptoms. Bring an example of a typical day's meals, including what you've stopped eating. This makes it easier to identify where your intake has changed.
Can you take an over-the-counter diarrhea medicine?
Check with a pharmacist or prescriber before choosing a product such as Imodium or Pepto-Bismol. Suitability depends on your medical history, other medicines, and accompanying symptoms.
NIDDK cautions against over-the-counter antidiarrheal medicines when you have blood in your stool or a fever. Tell the pharmacist about abdominal pain and recent antibiotics as well. Include anything you've already taken for this episode, including supplements.
Ask how to use the recommended product and when to check back if it hasn't helped. Repeatedly adding products can make it harder to keep track of what you've tried and how your symptoms have changed.
What to tell your prescriber
Keep your symptom notes and appointment planning together. A short record should cover:
Your medication name, formulation, prescribed dose, and dates of recent prescription changes.
When diarrhea began, how many loose stools you have a day, and whether it wakes you at night.
Whether stools are watery or bloody, and whether you also have pain, vomiting, or fever.
Your ability to drink and urinate, plus any medicines or supplements you've tried.
Mention recent antibiotics, travel and previous bowel conditions.
Describe the disruption plainly. Having to stay near a bathroom, missing work, or having an accident helps your clinician understand the effect beyond the stool count. Include whether symptoms happen after meals or on particular days.
Ask for a follow-up plan: how to manage difficulty eating or drinking, when to make contact again, and when another cause needs investigation. Report associated sulfur burps or alternating constipation so the discussion covers the whole bowel pattern.
When to get medical help
Call 911 for chest pain, trouble breathing, fainting or collapse.
Get medical help right away for severe or lasting abdominal pain, especially if it spreads to your back; vomiting blood or black or bloody stools; repeated vomiting, inability to keep fluids down or very little urine; a swollen, painful belly with inability to pass stool or gas; or upper-right abdominal pain with fever or yellow skin or eyes.
Trouble swallowing needs prompt medical assessment. If you can't swallow at all, go to an emergency department.
Sources: medication warnings, NIDDK, CDC and Mayo Clinic.
For diarrhea, contact a doctor right away if it lasts more than two days, you have six or more loose stools in a day, or you have a high fever. Seek help sooner for dehydration or severe symptoms.
Where gut-brain support fits
The gut and brain communicate in both directions, influencing digestive sensations and function. Gut-directed therapies are one way of addressing that connection. The American College of Gastroenterology's IBS guideline suggests gut-directed psychotherapies for global IBS symptoms.
In a 2004 study of 28 adults with refractory IBS, clinician-delivered hypnotherapy changed the colon's sensory and motor response to a laboratory fat infusion. Researchers measured responses in an IBS population; the study did not assess GLP-1 side effects.
Nerva combines gut-directed hypnotherapy, breathing and CBT-informed education to help you practice a calmer response to gut sensations. Daily guided audio sessions last around 15 minutes during the six-week core.
Nerva's trial studied adults with IBS. It hasn't been studied for GLP-1 diarrhea.
Explore Nerva alongside GLP-1 care, or read more about the gut-brain connection.
Ozempic, Wegovy and Rybelsus are trademarks of Novo Nordisk. Mounjaro, Zepbound and Foundayo are trademarks of Eli Lilly. Nerva is not affiliated with either company.
References
Novo Nordisk. Wegovy (semaglutide) US prescribing information. Revised June 2026. Adult injection Table 3. https://www.novo-pi.com/wegovy.pdf
Eli Lilly and Company. Zepbound (tirzepatide) US prescribing information. Revised August 2026. Section 6.1, Table 1. https://pi.lilly.com/us/zepbound-uspi.pdf
Novo Nordisk. Ozempic (semaglutide) injection US prescribing information. Revised May 2026. Section 6.1, Table 1. https://www.novo-pi.com/ozempic.pdf
Eli Lilly and Company. Mounjaro (tirzepatide) US prescribing information. Revised August 2026. Section 6.1, Table 1. https://pi.lilly.com/us/mounjaro-uspi.pdf
Novo Nordisk. Rybelsus and Ozempic tablets (semaglutide) US prescribing information. Revised January 2026. Table 2, Rybelsus trial formulation. https://www.novo-pi.com/rybelsus.pdf
Eli Lilly and Company. Foundayo (orforglipron) US prescribing information. Revised July 2026. Section 6.1, Table 1. https://pi.lilly.com/us/foundayo-uspi.pdf
National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Diarrhea. Reviewed September 2024. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/symptoms-causes
Wharton S, Calanna S, Davies M, et al. Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss. Diabetes Obes Metab. 2022;24:94-105. doi:10.1111/dom.14551. https://pmc.ncbi.nlm.nih.gov/articles/PMC9293236/
National Institute of Diabetes and Digestive and Kidney Diseases. Treatment of Diarrhea. Reviewed September 2024. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/treatment
National Institute of Diabetes and Digestive and Kidney Diseases. Eating, Diet, & Nutrition for Diarrhea. Reviewed September 2024. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/eating-diet-nutrition
National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of Diarrhea. https://www.niddk.nih.gov/health-information/digestive-diseases/diarrhea/diagnosis
Simren M, Ringstrom G, Bjornsson ES, Abrahamsson H. Treatment with hypnotherapy reduces the sensory and motor component of the gastrocolonic response in irritable bowel syndrome. Psychosom Med. 2004;66(2):233-238. doi:10.1097/01.psy.0000116964.76529.6e. https://pubmed.ncbi.nlm.nih.gov/15039508/
Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. Am J Gastroenterol. 2021;116(1):17-44. doi:10.14309/ajg.0000000000001036. https://pubmed.ncbi.nlm.nih.gov/33315591/
Anderson EJ, Peters SL, Gibson PR, Halmos EP. Comparison of Digitally Delivered Gut-Directed Hypnotherapy Program With an Active Control for Irritable Bowel Syndrome. Am J Gastroenterol. 2025;120(2):440-448. doi:10.14309/ajg.0000000000002921. https://pubmed.ncbi.nlm.nih.gov/38940439/
Centers for Disease Control and Prevention. About Heart Attack Symptoms, Risk, and Recovery. https://www.cdc.gov/heart-disease/about/heart-attack.html
Mindset Health. Nerva clinician overview. https://www.nervahealth.com/clinicians.
Mayo Clinic. Difficulty swallowing in adults: when to seek medical advice. https://www.mayoclinic.org/symptom-checker/difficulty-swallowing-in-adults-adult/related-factors/itt-20009075
